Table 1.
Demographic characteristics of the study population
| Parameters | LAIV1 | TIV1 |
|---|---|---|
| Number | 122 | 121 |
| Male | 65 (53%) | 64 (53%) |
| Female | 57 (47%) | 57 (47%) |
| White | 20 (16%) | 11 (9%) |
| Black | 72 (59%) | 82 (68%) |
| Hispanic | 27 (22%) | 26 (21%) |
| Age mean (min; 25%; 75%; max)2 | 11.4 (5; 9; 14; 18) | 11.9 (6; 10; 14; 18) |
| Entry CD4% Median (range) | 34.0 (15.0–51.0) | 34.0 (16.0–52.0) |
| Nadir CD4% Median (range) | 18.0 (1.0–41.0) | 17.0 (0.4–41.0) |
| Log10 Viral Load Mean (STD) | 2.7 (0.7) | 2.7 (0.7) |
| N (%) with Viral Load<400copies/mL | 87 (71) | 86 (71) |
| CD8% Median (range) | 32.0 (12.0–65.0) | 34.0 (15.0–58.0) |
| CD19% Median (range) | 19.0 (4.0–43.0) | 18.0 (5.0–47.0) |
1
LAIV = live attenuated influenza vaccine; TIV = trivalent influenza vaccine (inactivated)
2
min = minimum; max=maximum